Unicycive Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 02/13/2026 | 1.79 M | $10.33 M | 0.00% | 9.91% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 1.01 M | $5.86 B | 100.00% | 5.62% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 02/13/2026 | 939.20 K | $5.42 M | 0.00% | 5.20% |
| VANGUARD GROUP INC | 01/29/2026 | 788.59 K | $4.55 B | 19.69% | 4.37% |
| LOGOS GLOBAL MANAGEMENT LP | 02/17/2026 | 473.56 K | $2.73 M | 0.00% | 2.62% |
| CITADEL ADVISORS LLC | 02/17/2026 | 258.30 K | $1.49 B | 519.81% | 1.43% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 171.29 K | $989.21 M | 36.24% | 0.95% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 99.74 K | $575.51 M | 181,249.09% | 0.55% |
| OMERS ADMINISTRATION CORP | 02/13/2026 | 78.20 K | $451.21 K | 100.00% | 0.43% |
| STATE STREET CORP | 02/13/2026 | 65.23 K | $376.36 K | 18.97% | 0.36% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 55.31 K | $319.11 K | -52.86% | 0.31% |
| MORGAN STANLEY | 02/13/2026 | 46.58 K | $268.79 M | 338.97% | 0.26% |
| BLACKROCK, INC. | 02/12/2026 | 36.36 K | $209.77 M | 0.00% | 0.20% |
| XTX TOPCO LTD | 02/17/2026 | 35.41 K | $204.29 M | -6.39% | 0.20% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 26.30 K | $151.75 M | 100.00% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 24.93 K | $143.85 M | 100.00% | 0.14% |
| CHICAGO PARTNERS INVESTMENT GROUP LLC | 01/28/2026 | 22.41 K | $155.10 K | -16.87% | 0.12% |
| JANE STREET GROUP, LLC | 02/12/2026 | 20.90 K | $120.59 M | 100.00% | 0.12% |
| UBS GROUP AG | 01/29/2026 | 19.91 K | $114.85 M | 265.56% | 0.11% |
| CITADEL ADVISORS LLC | 02/17/2026 | 10.90 K | $62.89 M | 100.00% | 0.06% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 1.92 K | $11.08 K | 100.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 558 | $3.22 M | -0.36% | 0.00% |
| TFC FINANCIAL MANAGEMENT, INC. | 01/23/2026 | 300 | $1.73 K | 0.00% | 0.00% |
| CITIGROUP INC | 02/13/2026 | 228 | $1.32 K | -96.59% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 152 | $877.00 K | -81.62% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 02/09/2026 | 100 | $577 | 0.00% | 0.00% |
| BARCLAYS PLC | 02/13/2026 | 80 | $462.00 K | 0.00% | 0.00% |
| BOGART WEALTH, LLC | 01/30/2026 | 6 | $35 | 0.00% | 0.00% |
| DANSKE BANK A/S | 02/02/2026 | 1 | $6 | 0.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 0 | $0 | -100.00% | 0.00% |
| FORTITUDE FAMILY OFFICE, LLC | 01/15/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Unicycive Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 25 institutional investors and hedge funds held shares of Unicycive Therapeutics Inc. The most heavily invested institutionals were:
Vivo Capital, LLC: 1.79 M
Nantahala Capital Management, LLC: 939,202
VANGUARD GROUP INC: 788,587
GEODE CAPITAL MANAGEMENT, LLC: 171,290
BNP PARIBAS ARBITRAGE, SNC: 99,742
OMERS ADMINISTRATION Corp: 78,200
31.17% of Unicycive Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 4.23 M shares in the last 24 months. This purchase volume represents approximately $26.97 M in transactions.